215 related articles for article (PubMed ID: 33076300)
1. Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.
Kadnikov IA; Verbovaya ER; Voronkov DN; Voronin MV; Seredenin SB
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076300
[TBL] [Abstract][Full Text] [Related]
2. Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
Voronin MV; Kadnikov IA; Voronkov DN; Seredenin SB
Sci Rep; 2019 Nov; 9(1):17020. PubMed ID: 31745133
[TBL] [Abstract][Full Text] [Related]
3. Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.
Cuevas J; Behensky A; Deng W; Katnik C
J Pharmacol Exp Ther; 2011 Oct; 339(1):152-60. PubMed ID: 21715562
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole.
Voronin MV; Vakhitova YV; Tsypysheva IP; Tsypyshev DO; Rybina IV; Kurbanov RD; Abramova EV; Seredenin SB
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064275
[TBL] [Abstract][Full Text] [Related]
5. Treatment with afobazole at delayed time points following ischemic stroke improves long-term functional and histological outcomes.
Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Seifu S; McAleer J; Willing A; Cuevas J
Neurobiol Dis; 2014 Feb; 62():354-64. PubMed ID: 24141021
[TBL] [Abstract][Full Text] [Related]
6. The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats.
Hong WC; Yano H; Hiranita T; Chin FT; McCurdy CR; Su TP; Amara SG; Katz JL
J Biol Chem; 2017 Jul; 292(27):11250-11261. PubMed ID: 28495886
[TBL] [Abstract][Full Text] [Related]
7. Afobazole activation of σ-1 receptors modulates neuronal responses to amyloid-β25-35.
Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Pharmacol Exp Ther; 2013 Nov; 347(2):468-77. PubMed ID: 24006338
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-β25-35.
Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Pharmacol Exp Ther; 2013 Nov; 347(2):458-67. PubMed ID: 24006337
[TBL] [Abstract][Full Text] [Related]
9. Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
Cuevas J; Rodriguez A; Behensky A; Katnik C
J Pharmacol Exp Ther; 2011 Oct; 339(1):161-72. PubMed ID: 21715561
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
[TBL] [Abstract][Full Text] [Related]
12. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
[TBL] [Abstract][Full Text] [Related]
13. [Possible role of serotonin 5-HT2 receptors in mechanism of afobazole anxiolytic action: neurochemical study of inter-line differences in mice].
Raevskiĭ KS; Narkevich VB; Klodt PM; Kudrin VS
Eksp Klin Farmakol; 2011; 74(12):3-7. PubMed ID: 22379873
[TBL] [Abstract][Full Text] [Related]
14. Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke.
Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
J Neurochem; 2016 Nov; 139(3):497-509. PubMed ID: 27488244
[TBL] [Abstract][Full Text] [Related]
15. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
[TBL] [Abstract][Full Text] [Related]
16. [Afobazole decreases motor side effects induced by haloperidol].
Seredenin SB; Garibova TA; Kuznetsova AL; Voronin MV; Iarkova MA; Voronina TA
Eksp Klin Farmakol; 2009; 72(1):15-8. PubMed ID: 19334504
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
18. Effect of combined administration of afobazole and 5-HT2b/2c receptor antagonist SB-200646A on neurochemical profile of brain structures in C57Bl/6 and BALB/c mice.
Rayevsky KS; Narkevich VB; Klodt PM; Kudrin VS
Bull Exp Biol Med; 2012 Sep; 153(5):689-93. PubMed ID: 23113259
[TBL] [Abstract][Full Text] [Related]
19. [Effect of afobazole on the accumulation of free radical oxidation products and the catalase activity in rats with cerebral ischemia].
Silkina IV; Zenina TA; Seredenin SB; Mirzoian RS
Eksp Klin Farmakol; 2006; 69(4):47-50. PubMed ID: 16995439
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Guo CH; Cao T; Zheng LT; Waddington JL; Zhen XC
Acta Pharmacol Sin; 2020 Apr; 41(4):499-507. PubMed ID: 32112040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
